Kevin E. Lofton - 28 Sep 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Sep 2023, 20:09:35 UTC
Prior SEC filing
30 Jun 2023
Next SEC filing
29 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Edward S. Son by Power of Attorney for Kevin E. Lofton

Key filing fact

Kevin E. Lofton filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 29 Sep 2023.

Key facts

  • This page summarizes Kevin E. Lofton's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 29 Sep 2023, 20:09.

Change

  • Previous filing in this sequence was filed on 30 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GILD transaction Derivative

Phantom Stock

Award

Transaction value
$0
Shares
+31
Change %
+0.99%
Price
$0.000000
Shares after
3,195
Date
28 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
31
Exercise price
$0.000000
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

Footnote F2

Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

Footnote F3

The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .